These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15475446)

  • 1. High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence.
    Ayala G; Thompson T; Yang G; Frolov A; Li R; Scardino P; Ohori M; Wheeler T; Harper W
    Clin Cancer Res; 2004 Oct; 10(19):6572-8. PubMed ID: 15475446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer.
    Malik SN; Brattain M; Ghosh PM; Troyer DA; Prihoda T; Bedolla R; Kreisberg JI
    Clin Cancer Res; 2002 Apr; 8(4):1168-71. PubMed ID: 11948129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of Akt-1 in human prostate cancer: a computerized quantitative assessment with quantum dot technology.
    Li R; Dai H; Wheeler TM; Sayeeduddin M; Scardino PT; Frolov A; Ayala GE
    Clin Cancer Res; 2009 May; 15(10):3568-73. PubMed ID: 19417030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB.
    Van de Sande T; Roskams T; Lerut E; Joniau S; Van Poppel H; Verhoeven G; Swinnen JV
    J Pathol; 2005 Jun; 206(2):214-9. PubMed ID: 15880754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer.
    Prtilo A; Leach FS; Markwalder R; Kappeler A; Burkhard FC; Cecchini MG; Studer UE; Thalmann GN
    J Urol; 2005 Nov; 174(5):1814-8; discussion 1818. PubMed ID: 16217293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological significance and predictive value for biochemical recurrence of c-Fes expression in prostate cancer.
    Miyata Y; Watanabe S; Matsuo T; Hayashi T; Sakai H; Xuan JW; Greer PA; Kanda S
    Prostate; 2012 Feb; 72(2):201-8. PubMed ID: 21563194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
    Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
    Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer.
    Shah A; Swain WA; Richardson D; Edwards J; Stewart DJ; Richardson CM; Swinson DE; Patel D; Jones JL; O'Byrne KJ
    Clin Cancer Res; 2005 Apr; 11(8):2930-6. PubMed ID: 15837744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis.
    Diallo JS; Aldejmah A; Mouhim AF; Fahmy MA; Koumakpayi IH; Sircar K; Bégin LR; Mes-Masson AM; Saad F
    BJU Int; 2008 May; 101(10):1302-9. PubMed ID: 18294307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy.
    Okegawa T; Kinjo M; Nutahara K; Higashihara E
    Int J Urol; 2006 Sep; 13(9):1197-201. PubMed ID: 16984552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence.
    Li H; Zhang Y; Glass A; Zellweger T; Gehan E; Bubendorf L; Gelmann EP; Nevalainen MT
    Clin Cancer Res; 2005 Aug; 11(16):5863-8. PubMed ID: 16115927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics.
    Dai B; Kong YY; Ye DW; Ma CG; Zhou X; Yao XD
    BJU Int; 2009 Oct; 104(7):1009-16. PubMed ID: 19389013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer.
    Kreisberg JI; Malik SN; Prihoda TJ; Bedolla RG; Troyer DA; Kreisberg S; Ghosh PM
    Cancer Res; 2004 Aug; 64(15):5232-6. PubMed ID: 15289328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression.
    Osman I; Dai J; Mikhail M; Navarro D; Taneja SS; Lee P; Christos P; Shen R; Nanus DM
    Cancer; 2006 Dec; 107(11):2628-36. PubMed ID: 17083125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More than a marker... Phosphorylated Akt in prostate carcinoma.
    Stern DF
    Clin Cancer Res; 2004 Oct; 10(19):6407-10. PubMed ID: 15475426
    [No Abstract]   [Full Text] [Related]  

  • 19. [Endothelin-1 and receptor A: predictive value for biochemical relapse on patients with advanced and metastatic prostate cancer].
    Rotondo S; Menard J; Durlach A; Birembaut P; Staerman F
    Prog Urol; 2012 Jan; 22(1):38-44. PubMed ID: 22196004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer.
    Yip PY; Kench JG; Rasiah KK; Benito RP; Lee CS; Stricker PD; Henshall SM; Sutherland RL; Horvath LG
    Prostate; 2011 Nov; 71(15):1638-45. PubMed ID: 21432866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.